scholarly article | Q13442814 |
P2093 | author name string | Ji Wang | |
Mei X Wu | |||
Peiyu Li | |||
P2860 | cites work | Functional role of type I and type II interferons in antiviral defense | Q24276429 |
Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway | Q24306635 | ||
The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation | Q24316038 | ||
Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA | Q28118718 | ||
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity | Q28509328 | ||
Adjuvant solution for pandemic influenza vaccine production | Q30422038 | ||
Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury | Q31082239 | ||
Antigen depot is not required for alum adjuvanticity | Q34235031 | ||
Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects | Q34367481 | ||
The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling | Q34417115 | ||
High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants | Q34466125 | ||
Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs | Q34514089 | ||
Intradermal delivery of vaccines: potential benefits and current challenges | Q34601669 | ||
Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells | Q34977848 | ||
An update on the use of laser technology in skin vaccination | Q35017651 | ||
A micro-sterile inflammation array as an adjuvant for influenza vaccines | Q35208463 | ||
Effective and lesion-free cutaneous influenza vaccination | Q35549338 | ||
The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo | Q35595683 | ||
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity | Q35634752 | ||
Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. | Q35836140 | ||
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant | Q36097099 | ||
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens | Q36395541 | ||
MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals | Q36845998 | ||
c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection. | Q37109444 | ||
Understanding the murine cutaneous dendritic cell network to improve intradermal vaccination strategies. | Q37807923 | ||
Immune sensing of DNA | Q38109307 | ||
Key roles of adjuvants in modern vaccines | Q38169040 | ||
Bacterial c-di-GMP is an immunostimulatory molecule | Q44754791 | ||
T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. | Q54026692 | ||
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. | Q55041754 | ||
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes | Q56987878 | ||
Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations | Q72996305 | ||
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties | Q79450264 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bites and stings | Q54911704 |
P304 | page(s) | 2183-2191 | |
P577 | publication date | 2016-06-07 | |
P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
P1476 | title | Natural STING Agonist as an "Ideal" Adjuvant for Cutaneous Vaccination | |
P478 | volume | 136 |
Q64927032 | A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity. |
Q47573396 | A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination |
Q57291393 | Assessment of Th1/Th2 bias of STING agonists coated on microneedles for possible use in skin allergen immunotherapy |
Q92539071 | Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice |
Q92267263 | DNA sensing by the cGAS-STING pathway in health and disease |
Q90391422 | Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation |
Q90705207 | Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant |
Q47169865 | Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization. |
Q59351768 | Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy |
Q33704771 | Involvement of GATA1 and Sp3 in the activation of the murine STING gene promoter in NIH3T3 cells |
Q47708661 | Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid |
Q89808497 | Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity |
Q38694896 | Purification of Cyclic GMP-AMP from Viruses and Measurement of Its Activity in Cell Culture |
Q92252408 | Resistance to ectromelia virus infection requires cGAS in bone marrow-derived cells which can be bypassed with cGAMP therapy |
Q50155142 | Routing dependent immune responses after experimental R848-adjuvated vaccination |
Q56890719 | Small-Molecule Targets in Tumor Immunotherapy |
Q39432584 | Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses. |
Q58698133 | Topical Application of a Vitamin A Derivative and Its Combination With Non-ablative Fractional Laser Potentiates Cutaneous Influenza Vaccination |
Q47170879 | cGAMP Promotes Germinal Center Formation and Production of IgA in Nasal-Associated Lymphoid Tissue |
Q38972881 | cGAS-cGAMP-STING: The three musketeers of cytosolic DNA sensing and signaling |
Search more.